GlassScriptPhysician profile
Sidharth C Panchamia
NPI 1275735276
$21,598.61
in general payments reported to CMS, 2019-2025
43 companies · $783 in 2025
The $783 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,968 · 2020: $8,282 · 2021: $4,846 · 2022: $3,110 · 2023: $515 · 2024: $2,094 · 2025: $783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,348 · Travel and Lodging: $1,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,348.31 |
| Travel and Lodging | $1,044.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ziehm-Orthoscan, INC. | $10,631.91 | 2020-2022 | |
| Boston Scientific Corporation | $4,543.69 | 2020-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Vertos Medical, INC. | $1,225.79 | 2019-2023 | Mild Device Kit |
| Si-Bone, INC. | $1,222.69 | 2023-2025 | |
| Spinal Simplicity, LLC | $834.22 | 2021-2024 | Ha Minuteman G3-R |
| Abbott Laboratories | $813.55 | 2019-2024 | Eterna, Proclaim |
| Spr Therapeutics, INC | $305.01 | 2022-2025 | Sprint Pns System |
| Nevro Corp. | $192.47 | 2019-2024 | Senza |
| Collegium Pharmaceutical, INC. | $160.22 | 2019-2021 | |
| Almatica Pharma LLC | $139.19 | 2021-2023 | Gralise |
| Scilex Pharmaceuticals INC. | $136.78 | 2019-2021 | |
| Spinefrontier, INC. | $128.87 | 2024 | Inspan, Sijfuse, Nanofuse |
| Amgen INC. | $109.26 | 2019-2022 | |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $95.62 | 2021-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sidharth Panchamia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.